EMGALITY FDA approval date

The FDA approved EMGALITY on 27 Sep 2018.

FDA approval date
27 Sep 2018

Drug identity has not yet been verified against registry records

Also recorded as GALCANEZUMAB-GNLM

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2018-09-27DayEMGALITYFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA761063", "applicant_as_listed_by_fda": "ELI LILLY AND CO", "brand_names": ["EMGALITY"], "active_ingredients": ["GALCANEZUMAB-GNLM"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20180927", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026